EZH2 and hepatocellular carcinoma: Moreover, Guo et al. 51 reported that overexpression of DLEU2 can promote tumorigenesis in hepatocellular carcinoma (HCC) by interacting with the zeste 2 polycomb repressive complex 2 subunit (EZH2).